Metabolomics Market Expected to Reach $3,301 Million by 2023

1
Metabolomics Market Is Expected To Grow At a
Lucrative Rate 2023

• The biomarker discovery segment accounted for the
  highest market share in 2016, and is expected to
  continue this trend during the forecast period.

2
Intro
Global Metabolomics Market was valued at 1,379
million in 2016, and is estimated to reach 3,301
million by 2023, registering a CAGR of 13.2 from
2017 to 2023. Metabolomics is the study and
analysis of the biochemical processes involving
intermediates and byproducts of metabolic
activities.
3

• Key Benefits
• Get PDF Sample Of Research Report
  https//goo.gl/auQndT
• The report entails a detailed quantitative
  analysis of the current market trends from 2016
  to 2023 to identify the prevailing opportunities.
• Market estimations of the industry are provided
  based on the comprehensive analysis of the key
  developments in the industry.
• In-depth analysis based on geography assists to
  understand the regional market and the strategic
  business planning.

4

• Metabolomics Market Key Segments
• Metabolomics Instruments
• Separation Techniques
• High-performance Liquid Chromatography
• Gas Chromatography
• Ultra-performance Liquid Chromatography
• Capillary Electrophoresis.
• Detection Techniques
• Mass Spectrometry
• Nuclear Magnetic Resonance Spectroscopy
• Surface-based Mass Analysis
• Metabolomics Bioinformatics Tools Services
• Bioinformatics Tools and Database
• Bioinformatics Services

5

• By Application
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine

Request For Customization https//goo.gl/5BM9Mn
6

• List of players profiled in the report
• Agilent Technologies, Inc.,
• Danaher Corporation,
• Biocrates Life Sciences AG,
• Bruker Corporation,
• Leco Corporation,
• Metabolon, Inc.,
• Human Metabolome Technologies, Inc.,
• Bio-Rad Laboratories, Inc.,
• Shimadzu Corporation,
• Waters Corporation, and
• Thermo Fisher Scientific Inc.